Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 12,733.1 | 11,790.2 | 12,562.0 | 12,222.1 | 13,835.9 | 13,151.8 | 13,545.1 | 14,280.5 |
| Revenue growth | 8.0% | -6.1% | 2.8% | -11.7% | 5.2% | -2.9% | -5.1% | 7.7% |
| Cost of goods sold | 7,615.8 | 6,905.8 | 7,045.8 | 6,875.3 | 8,064.2 | 7,533.9 | 7,223.5 | 7,679.1 |
| Gross profit | 5,117.3 | 4,884.4 | 5,516.2 | 5,346.8 | 5,771.7 | 5,617.9 | 6,321.6 | 6,601.4 |
| Gross margin | 40.2% | 41.4% | 43.9% | 43.7% | 41.7% | 42.7% | 46.7% | 46.2% |
| Selling, general and administrative | 3,416.1 | 3,309.1 | 3,550.8 | 3,505.8 | 3,825.3 | 3,708.2 | 4,345.5 | 4,577.6 |
| EBITA | 1,940.2 | 1,794.3 | 2,171.4 | 2,034.0 | 2,254.4 | 2,199.7 | 2,268.1 | 2,328.8 |
| EBITA margin | 15.2% | 15.2% | 17.3% | 16.6% | 16.3% | 16.7% | 16.7% | 16.3% |
| Amortization of intangibles | 239.0 | 219.0 | 206.0 | 193.0 | 308.0 | 290.0 | 292.0 | 305.0 |
| EBIT | 1,701.2 | 1,575.3 | 1,965.4 | 1,841.0 | 1,946.4 | 1,909.7 | 1,976.1 | 2,023.8 |
| EBIT margin | 13.4% | 13.4% | 15.6% | 15.1% | 14.1% | 14.5% | 14.6% | 14.2% |
| Pre-tax income | 1,414.2 | 1,161.4 | 1,731.5 | 1,587.1 | 1,762.4 | 1,649.4 | 1,317.7 | 1,698.4 |
| Income taxes | 270.2 | 176.6 | 288.6 | 321.2 | 243.8 | 402.9 | 300.5 | 476.2 |
| Tax rate | 19.1% | 15.2% | 16.7% | 20.2% | 13.8% | 24.4% | 22.8% | 28.0% |
| Earnings from continuing ops | 1,129.9 | -1,205.1 | 1,558.9 | 1,429.1 | 1,504.6 | 1,229.0 | 1,002.1 | 1,202.8 |
| Earnings from discontinued ops | | 0.0 | 0.0 | 0.0 | | | | |
| Net income | 1,129.9 | -1,205.1 | 1,558.9 | 1,429.1 | 1,504.6 | 1,229.0 | 1,002.1 | 1,202.8 |
| Net margin | 8.9% | -10.2% | 12.4% | 11.7% | 10.9% | 9.3% | 7.4% | 8.4% |
| |
| Diluted EPS | $3.91 | ($4.15) | $5.33 | $4.88 | $5.12 | $4.14 | $3.32 | $3.93 |
| Shares outstanding (diluted) | 289.1 | 290.3 | 292.5 | 292.8 | 294.0 | 296.7 | 301.4 | 305.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|